Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis

AI SummaryThis cohort study compares the effectiveness of rituximab and ocrelizumab in preventing relapses and disability in patients with relapsing-remitting multiple sclerosis.This cohort study investigates if rituximab is noninferior to ocrelizumab in the prevention of relapses and disability in patients with relapsing-remitting multiple sclerosis.

Safety and Efficacy of ApTOLL in Patients With Ischemic Stroke Undergoing Endovascular Treatment

AI SummaryThis randomized clinical trial examines the safety and effectiveness of ApTOLL as a neuroprotectant drug when combined with endovascular treatment for patients with ischemic stroke.This randomized clinical trial investigates the safety and efficacy of ApTOLL as a neuroprotectant drug for patients with ischemic stroke when given in combination with endovascular treatment.

Error in Figure 3

AI SummaryThe wrong image was published for Figure 3 in the Original Investigation titled “Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes.” The article has been corrected online.In the Original Investigation titled “Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes,” which was published… Continue reading Error in Figure 3

Error in Figure 2

In the Original Investigation titled “Effectiveness of Lumbar Cerebrospinal Fluid Drain Among Patients With Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial,” published online June 18, 2023, there was an error in the lumbar drain group in Figure 2. The value was updated from 24 to 9 for the group with a modified Rankin Scale score… Continue reading Error in Figure 2

[Comment] NfL is ready for translation into paediatrics

Diagnostic and therapeutic advancements for neurological conditions will be aided by progress in biomarker research across the age span. Ultrasensitive detection assays for neurofilament light chain (NfL) have emerged as validated soluble protein measures of neuroaxonal injury.1 Abnormally elevated blood and CSF concentrations of NfL correlate with the extent of CNS injury (providing prognostic and… Continue reading [Comment] NfL is ready for translation into paediatrics

[Articles] Serum neurofilament light chain reference database for individual application in paediatric care: a retrospective modelling and validation study

AI SummaryThe use of sNfL Z score in children and adolescents allows for more accurate estimation of neuroaxonal damage in individual patients than absolute sNfL values. Summary unavailable.The established normative sNfL values in children and adolescents provide a foundation for the clinical application of sNfL in the paediatric population. Compared with absolute sNfL values, the… Continue reading [Articles] Serum neurofilament light chain reference database for individual application in paediatric care: a retrospective modelling and validation study